This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Cefazolin for injection - 1gm and 10gm PWS
- Starting date:
- March 14, 2013
- Posting date:
- April 2, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26487
Recalled Products
- Cefazolin for injection - 10 gm PWS
- Cefazolin for injection - 1 gm PWS
Reason
Teva Canada initiated the voluntary recall due to the presence of particulate matter in the product upon reconstitution.
Depth of distribution
Recall to retail level: Distribution in Canada.
Affected products
A. Cefazolin for injection - 10 gm PWS
DIN, NPN, DIN-HIM
DIN 02108135
Dosage form
- Powder for Solution
Strength
- 10 g / vial
Lot or serial number
- 352276
- 352277
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
B. Cefazolin for injection - 1 gm PWS
DIN, NPN, DIN-HIM
DIN 02108127
Dosage form
- Powder for Solution
Strength
- 1 g / vial
Lot or serial number
- 360301
- 360302
Companies
- Recalling Firm
-
Teva - Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Novopharm Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA